Care Delivery

This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.

artificial intelligence AI in healthcare

Stanford HAI lookback: Best-read blog posts of 2024

The year 2023 saw a shift toward open-source AI models, surging investments in generative AI and increasing AI regulation.

IV hospital room intravenous drip solution

Industry Watcher’s Digest

The FDA has finalized its recommendations for getting AI-equipped medical devices approved. 

artificial intelligence AI in healthcare

Providers, payers share actionable experiences involving healthcare AI

A large venture capital firm focused on supporting early-stage healthtech companies has a tip for AI startups targeting the healthcare sector.

Robotic aortic valve replacement (RAVR) is a new minimally invasive treatment option for symptomatic severe aortic stenosis (AS) that uses advanced robotic surgical systems. It has already started gaining momentum as an alternative to both surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR).

Q&A: Pioneer heart surgeon on the development and long-term potential of robotic aortic valve replacement

It's early for RAVR, but the minimally invasive technique has already started gaining momentum as an alternative to both SAVR and TAVR. We spoke to Vinay Badhwar, MD, one of the world’s leading voices in robotic heart surgery, to learn more.

Heart surgeons with the WVU Heart and Vascular Institute have made a bit of history, performing the world’s first combined robotic aortic valve replacement (AVR) and coronary artery bypass grafting (CABG) procedure—all through one small incision. Patients requiring these procedures typically undergo open-heart surgery.

Heart surgeons perform world’s first combined robotic AVR and CABG

The entire robotic procedure was performed through one small incision. Surgeons originally recommended the 73-year-old patient undergo open-heart surgery, but she requested a less invasive alternative. 

Off-label TAVR for native aortic regurgitation linked to worse outcomes

Targeting aortic regurgitation with TAVR valves built to treat aortic stenosis may be the only option a cardiologist has—but valves designed specifically to treat AR are linked to much better outcomes, according to a new meta-analysis. Edwards Lifesciences recently acquired the two companies at the center of this study, JenaValve and JC Medical.

Artificial intelligence AI in healthcare

Industry Watcher’s Digest

Federal AI guardrails are taking shape.

artificial intelligence AI in healthcare

Healthcare-specific AI: How to multiply successes and head off accidents

Given the rapid proliferation of AI-equipped medical devices across U.S. healthcare, unintended effects should surprise no one.